Talaris Therapeutics, Inc.

NasdaqGM:TALS Stok Raporu

Piyasa değeri: US$553.2m

Talaris Therapeutics Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Mary Fenton

İcra Kurulu Başkanı

US$2.2m

Toplam tazminat

CEO maaş yüzdesi20.6%
CEO görev süresi2.6yrs
CEO sahipliği0.07%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi4.9yrs

Son yönetim güncellemeleri

Recent updates

Will Talaris Therapeutics (NASDAQ:TALS) Spend Its Cash Wisely?

May 24
Will Talaris Therapeutics (NASDAQ:TALS) Spend Its Cash Wisely?

Is Talaris Therapeutics (NASDAQ:TALS) In A Good Position To Invest In Growth?

Feb 14
Is Talaris Therapeutics (NASDAQ:TALS) In A Good Position To Invest In Growth?

We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate

Oct 21
We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate

Talaris drops 24% after patient death in late-stage trial for lead asset

Oct 20

Talaris Therapeutics: Plenty Of Upside Remains, But So Does The Risk

Aug 29

Talaris Therapeutics GAAP EPS of -$0.44

Aug 15

We're Not Very Worried About Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate

Jul 06
We're Not Very Worried About Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate

Talaris Therapeutics achieves positive results in phase 3 kidney transplant drug trial

Jun 30

Talaris Therapeutics (NASDAQ:TALS) Is In A Good Position To Deliver On Growth Plans

Mar 23
Talaris Therapeutics (NASDAQ:TALS) Is In A Good Position To Deliver On Growth Plans

Talaris Therapeutics EPS beats by $0.49

Jun 14

CEO Tazminat Analizi

Mary Fenton'un ücretlendirmesi Talaris Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2023n/an/a

-US$75m

Mar 31 2023n/an/a

-US$78m

Dec 31 2022US$2mUS$455k

-US$74m

Sep 30 2022n/an/a

-US$70m

Jun 30 2022n/an/a

-US$64m

Mar 31 2022n/an/a

-US$57m

Dec 31 2021US$2mUS$340k

-US$48m

Tazminat ve Piyasa: Mary 'ın toplam tazminatı ($USD 2.21M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.18M ).

Tazminat ve Kazançlar: Mary 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Mary Fenton (59 yo)

2.6yrs

Görev süresi

US$2,209,223

Tazminat

Ms. Mary Kay Fenton has been Chief Financial Officer at Talaris Therapeutics, Inc. since March 2021 and serves as its Treasurer and has been its Interim CEO and President since May 26, 2023. She had been a...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Suzanne Ildstad
Founder21.7yrsUS$1.33m11.88%
$ 65.7m
Mark McDade
Independent Director4.9yrsUS$130.42k0%
$ 0
Geoff MacKay
Independent Director4.9yrsUS$135.05k0%
$ 0
Sapna Srivastava
Independent Director2.8yrsUS$137.92k0%
$ 0
Francois Nader
Independent Chairman4.9yrsUS$175.92k0.90%
$ 5.0m
Sandip Agarwala
Independent Director4.9yrsUS$130.42k0%
$ 0
Karen Smith
Independent Director1.4yrsUS$249.58k0%
$ 0
Gaurav Shah
Independent Director2.8yrsUS$126.92k0%
$ 0

4.9yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TALS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.9 yıldır).